Alzhanov,D., Barnes,J., Hruby,D.E., and Rockey,D.D. (2004). Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA. BMC. Microbiol. 4, 24.
Anderson,D.M. and Schneewind,O. (1999). Type III machines of Gram-negative pathogens: injecting virulence factors into host cells and more. Curr. Opin. Microbiol. 2, 18-24.
Anttila,T., Saikku,P., Koskela,P., Bloigu,A., Dillner,J., Ikaheimo,I., Jellum,E., Lehtinen,M., Lenner,P., Hakulinen,T., Narvanen,A., Pukkala,E., Thoresen,S., Youngman,L., and Paavonen,J. (2001). Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285, 47-51.
Bannantine,J.P., Stamm,W.E., Suchland,R.J., and Rockey,D.D. (1998). Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect. Immun. 66, 6017-6021.
Bas,S., Muzzin,P., Ninet,B., Bornand,J.E., Scieux,C., and Vischer,T.L. (2001). Chlamydial serology: comparative diagnostic value of Immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J. Clin. Microbiol. 39, 1368-1377.
Batteiger,B.E., Rank,R.G., Bavoil,P.M., and Soderberg,L.S. (1993). Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J. Gen. Microbiol. 139 ( Pt 12), 2965-2972.
Bavoil,P.M. and Hsia,R.C. (1998). Type III secretion in Chlamydia: a case of deja vu? Mol. Microbiol. 28, 860-862.
Belland,R.J., Zhong,G., Crane,D.D., Hogan,D., Sturdevant,D., Sharma,J., Beatty,W.L., and Caldwell,H.D. (2003). Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. U. S. A 100, 8478-8483.
Betsou,F., Sueur,J.M., and Orfila,J. (1999). Serological investigation of Chlamydia trachomatis heat shock protein 10. Infect. Immun. 67, 5243-5246.
Brown,W.J., Skeiky,Y.A., Probst,P., and Rockey,D.D. (2002). Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol. Infect. Immun. 70, 5860-5864.
Brunham,R.C. and Rey-Ladino,J. (2005). Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5, 149-161.
Brunham,R.C., Zhang,D.J., Yang,X., and McClarty,G.M. (2000). The potential for vaccine development against chlamydial infection and disease. J. Infect. Dis. 181 Suppl 3, S538-S543.
Caldwell,H.D., Kromhout,J., and Schachter,J. (1981). Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31, 1161-1176.
Cevenini,R., Rumpianesi,F., Sambri,V., and La Placa,M. (1986). Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by Immunoblotting. J. Clin. Pathol. 39, 325-327.
Delevoye,C., Nilges,M., Dautry-Varsat,A., and Subtil,A. (2004). Conservation of the biochemical properties of IncA from chlamydia trachomatis and C. caviae : oligomerization of IncA mediates interaction between facing membranes. J. Biol. Chem.
Eckert,L.O., Suchland,R.J., Hawes,S.E., and Stamm,W.E. (2000). Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J. Infect. Dis. 182, 540-544.
Eko,F.O., He,Q., Brown,T., McMillan,L., Ifere,G.O., Ananaba,G.A., Lyn,D., Lubitz,W., Kellar,K.L., Black,C.M., and Igietseme,J.U. (2004). A novel recombinant multisubunit vaccine against Chlamydia. J. Immunol. 173, 3375-3382.
Eko,F.O., Lubitz,W., McMillan,L., Ramey,K., Moore,T.T., Ananaba,G.A., Lyn,D., Black,C.M., and Igietseme,J.U. (2003). Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine 21, 1694-1703.
Fan,T., Lu,H., Hu,H., Shi,L., McClarty,G.A., Nance,D.M., Greenberg,A.H., and Zhong,G. (1998). Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187, 487-496.
Fields,K.A., Fischer,E., and Hackstadt,T. (2002). Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA. Infect. Immun. 70, 3816-3823.
Fields,K.A., Mead,D.J., Dooley,C.A., and Hackstadt,T. (2003). Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol. Microbiol. 48, 671-683.
Fling,S.P., Sutherland,R.A., Steele,L.N., Hess,B., D'Orazio,S.E., Maisonneuve,J., Lampe,M.F., Probst,P., and Starnbach,M.N. (2001). CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. U. S. A 98, 1160-1165.
Grandi,G. (2003). Rational antibacterial vaccine design through genomic technologies. Int. J. Parasitol. 33, 615-620.
Grayston,J.T., Woodlridge,R.L., Wang,S.P., Yen,C.H., Yang,C.Y., Cheng,K.H., and Chang,I.H. (1963). Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan. Proc. Soc. Exp. Biol. Med. 112, 589-595.
Hackstadt,T., Fischer,E.R., Scidmore,M.A., Rockey,D.D., and Heinzen,R.A. (1997). Origins and functions of the chlamydial inclusion. Trends Microbiol. 5, 288-293.
Hackstadt,T., Scidmore-Carlson,M.A., Shaw,E.I., and Fischer,E.R. (1999). The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol. 1, 119-130.
Hsia,R.C., Pannekoek,Y., Ingerowski,E., and Bavoil,P.M. (1997). Type III secretion genes identify a putative virulence locus of Chlamydia. Mol. Microbiol. 25, 351-359.
Hueck,C.J. (1998). Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62, 379-433.
Igietseme,J.U., Ananaba,G.A., Bolier,J., Bowers,S., Moore,T., Belay,T., Eko,F.O., Lyn,D., and Black,C.M. (2000). Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J. Immunol. 164, 4212-4219.
Igietseme,J.U., Eko,F.O., He,Q., Bandea,C., and Black,C.M. (2004). Developing effective delivery systems for Chlamydia vaccines. Curr. Opin. Mol. Ther. 6, 182-194.
Jager,D., Stockert,E., Karbach,J., Herrlinger,K., Atmaca,A., Arand,M., Chen,Y.T., Gnjatic,S., Old,L.J., Knuth,A., and Jager,E. (2002). Urine antibody against human cancer antigen NY-ESO-1. Cancer Immun. 2, 10.
Johansson,M. and Lycke,N.Y. (2003). Immunology of the human genital tract. Curr. Opin. Infect. Dis. 16, 43-49.
Koehler,J.E., Birkelund,S., and Stephens,R.S. (1992). Overexpression and surface localization of the Chlamydia trachomatis major outer membrane protein in Escherichia coli. Mol. Microbiol. 6, 1087-1094.
Kohl,K.S., Markowitz,L.E., and Koumans,E.H. (2003). Developments in the screening for Chlamydia trachomatis: a review. Obstet. Gynecol. Clin. North Am. 30, 637-658.
Lampe,M.F., Wilson,C.B., Bevan,M.J., and Starnbach,M.N. (1998). Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect. Immun. 66, 5457-5461.
Lenart,J., Andersen,A.A., and Rockey,D.D. (2001). Growth and development of tetracycline-resistant Chlamydia suis. Antimicrob. Agents Chemother. 45, 2198-2203.
Longbottom,D. (2003). Chlamydial vaccine development. J. Med. Microbiol. 52, 537-540.
Longbottom,D., Russell,M., Dunbar,S.M., Jones,G.E., and Herring,A.J. (1998). Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect. Immun. 66, 1317-1324.
Lysen,M., Osterlund,A., Rubin,C.J., Persson,T., Persson,I., and Herrmann,B. (2004). Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County. J. Clin. Microbiol. 42, 1641-1647.
Martin,D.H., Mroczkowski,T.F., Dalu,Z.A., McCarty,J., Jones,R.B., Hopkins,S.J., and Johnson,R.B. (1992). A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N. Engl. J. Med. 327, 921-925.
Mbizvo,E.M., Msuya,S.E., Stray-Pedersen,B., Sundby,J., Chirenje,M.Z., and Hussain,A. (2001). HIV seroprevalence and its associations with the other reproductive tract infections in asymptomatic women in Harare, Zimbabwe. Int. J. STD AIDS 12, 524-531.
Mestecky,J. and Fultz,P.N. (1999). Mucosal immune system of the human genital tract. J. Infect. Dis. 179 Suppl 3, S470-S474.
Mestecky,J., Moldoveanu,Z., and Russell,M.W. (2005). Immunologic uniqueness of the genital tract: challenge for vaccine development. Am. J. Reprod. Immunol. 53, 208-214.
Miller,W.C., Ford,C.A., Morris,M., Handcock,M.S., Schmitz,J.L., Hobbs,M.M., Cohen,M.S., Harris,K.M., and Udry,J.R. (2004). Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291, 2229-2236.
Moore,T., Ekworomadu,C.O., Eko,F.O., MacMillan,L., Ramey,K., Ananaba,G.A., Patrickson,J.W., Nagappan,P.R., Lyn,D., Black,C.M., and Igietseme,J.U. (2003). Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J. Infect. Dis. 188, 617-624.
Morre,S.A., Rozendaal,L., van Valkengoed,I.G., Boeke,A.J., Voorst Vader,P.C., Schirm,J., de Blok,S., van Den Hoek,J.A., van Doornum,G.J., Meijer,C.J., and van Den Brule,A.J. (2000). Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations? J. Clin. Microbiol. 38, 2292-2296.
Moulder,J.W. (1991). Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55, 143-190.
Murdin,A.D., Gellin,B., Brunham,R.C., Campbell,L.A., Christiansen,G., Deal,C.D., Jenson,H.B., Metcalf,B., Sankaran,B., Stephens,R.S., and Wilfert,C. (2000). Collaborative multidisciplinary workshop report: progress toward a Chlamydia pneumoniae vaccine. J. Infect. Dis. 181 Suppl 3, S552-S557.
Newhall,W.J., Batteiger,B., and Jones,R.B. (1982). Analysis of the human serological response to proteins of Chlamydia trachomatis. Infect. Immun. 38, 1181-1189.
Okada,C., Kura,F., Wada,A., Inagawa,H., Lee,G.H., and Matsushita,H. (2002). Cross-reactivity and sensitivity of two Legionella urinary antigen kits, Biotest EIA and Binax NOW, to extracted antigens from various serogroups of L. pneumophila and other Legionella species. Microbiol. Immunol. 46, 51-54.
Oriel,J.D., Ridgway,G.L., and Tchamouroff,S. (1977). Comparison of erythromycin stearate and oxytetracycline in the treatment of non-gonococcal urethritis: their efficacy against Chlamydia trachomatis. Scott. Med. J. 22, 375-379.
Parish,W.L., Laumann,E.O., Cohen,M.S., Pan,S., Zheng,H., Hoffman,I., Wang,T., and Ng,K.H. (2003). Population-based study of chlamydial infection in China: a hidden epidemic. JAMA 289, 1265-1273.
Peipert,J.F. (2003). Clinical practice. Genital chlamydial infections. N. Engl. J. Med. 349, 2424-2430.
Perry,L.L., Feilzer,K., and Caldwell,H.D. (1997). Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol. 158, 3344-3352.
Rasmussen,S.J., Eckmann,L., Quayle,A.J., Shen,L., Zhang,Y.X., Anderson,D.J., Fierer,J., Stephens,R.S., and Kagnoff,M.F. (1997). Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest 99, 77-87.
Rockey,D.D., Lenart,J., and Stephens,R.S. (2000). Genome sequencing and our understanding of chlamydiae. Infect. Immun. 68, 5473-5479.
Rockey,D.D., Scidmore,M.A., Bannantine,J.P., and Brown,W.J. (2002). Proteins in the chlamydial inclusion membrane. Microbes. Infect. 4, 333-340.
Samra,Z., Rosenberg,S., Soffer,Y., and Dan,M. (2001). In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. Diagn. Microbiol. Infect. Dis. 39, 177-179.
Schachter,J. (1978). Chlamydial infections (first of three parts). N. Engl. J. Med. 298, 428-435.
Scidmore,M.A. and Hackstadt,T. (2001). Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol. Microbiol. 39, 1638-1650.
Scidmore-Carlson,M.A., Shaw,E.I., Dooley,C.A., Fischer,E.R., and Hackstadt,T. (1999). Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol. Microbiol. 33, 753-765.
Shaw,E.I., Dooley,C.A., Fischer,E.R., Scidmore,M.A., Fields,K.A., and Hackstadt,T. (2000). Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol. Microbiol. 37, 913-925.
Shimizu,T., Yarita,Y., Haruna,H., Kaneko,K., Yamashiro,Y., Gupta,R., Anazawa,A., and Suzuki,K. (2003). Urine-based enzyme-linked immunosorbent assay for the detection of Helicobacter pylori antibodies in children. J. Paediatr. Child Health 39, 606-610.
Smith,J.S., Munoz,N., Herrero,R., Eluf-Neto,J., Ngelangel,C., Franceschi,S., Bosch,F.X., Walboomers,J.M., and Peeling,R.W. (2002). Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J. Infect. Dis. 185, 324-331.
Somani,J., Bhullar,V.B., Workowski,K.A., Farshy,C.E., and Black,C.M. (2000). Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. 181, 1421-1427.
Starnbach,M.N., Loomis,W.P., Ovendale,P., Regan,D., Hess,B., Alderson,M.R., and Fling,S.P. (2003). An Inclusion Membrane Protein from Chlamydia trachomatis Enters the MHC Class I Pathway and Stimulates a CD8(+) T Cell Response. J. Immunol. 171, 4742-4749.
Stuart,E.S., Tirrell,S.M., and MacDonald,A.B. (1987). Characterization of an antigen secreted by Chlamydia-infected cell culture. Immunology 61, 527-533.
Su,H., Feilzer,K., Caldwell,H.D., and Morrison,R.P. (1997). Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65, 1993-1999.
Subtil,A., Blocker,A., and Dautry-Varsat,A. (2000). Type III secretion system in Chlamydia species: identified members and candidates. Microbes. Infect. 2, 367-369.
Subtil,A., Parsot,C., and Dautry-Varsat,A. (2001). Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol. Microbiol. 39, 792-800.
Suchland,R.J., Eckert,L.O., Hawes,S.E., and Stamm,W.E. (2003). Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex Transm. Dis. 30, 357-361.
Suchland,R.J., Rockey,D.D., Bannantine,J.P., and Stamm,W.E. (2000). Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect. Immun. 68, 360-367.
Taylor,H.R. and Prendergast,R.A. (1987). Attempted oral immunization with chlamydial lipopolysaccharide subunit vaccine. Invest Ophthalmol. Vis. Sci. 28, 1722-1726.
Taylor,H.R., Whittum-Hudson,J., Schachter,J., Caldwell,H.D., and Prendergast,R.A. (1988). Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophthalmol. Vis. Sci. 29, 1847-1853.
van Duynhoven,Y.T., Ossewaarde,J.M., Derksen-Nawrocki,R.P., van der Meijden,W.I., and van de Laar,M.J. (1998). Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients' characteristics. Clin. Infect. Dis. 26, 314-322.
Whelan,J. (2002). Potential new vaccine against chlamydia. Drug Discov. Today 7, 843-844.
Woolridge,R.L., Grayston,J.T., Chang,I.H., Yang,C.Y., and Cheng,K.H. (1967). Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am. J. Ophthalmol. 63, Suppl-5.
Wu,I.C., Ke,H.L., Lo,Y.C., Yang,Y.C., Chuang,C.H., Yu,F.J., Lee,Y.C., Jan,C.M., Wang,W.M., and Wu,D.C. (2003). Evaluation of a newly developed office-based stool test for detecting Helicobacter pylori: an extensive pilot study. Hepatogastroenterology 50, 1761-1765.
Zhong,G., Fan,P., Ji,H., Dong,F., and Huang,Y. (2001). Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193, 935-942.
Zhu,C., Tian,H., Lu,L., Li,Y., Feng,Z., Ma,L., and Guan,X. (2000). A study on producing monoclonal antibody with one diagnostic marker screened electrophoretically from the urine of individuals infected with Schistosoma japonicum. Diagn. Microbiol. Infect. Dis. 38, 237-241.
World Health Organization. (2001). Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases: Chlamydia estimates. World Health Organization, Geneva, Switzerland.
張銘芳 (1988) 婦產科門診病人砂眼披衣菌感染之流行病學研究 陽明醫學院公衛所碩士論文楊順晴 (1999) 婦女感染生殖道披衣菌之流行病學調查:以尿液為檢體篩檢披衣菌感染可行性之評估及婦女感染披衣菌危險因子之分析 國防醫學院公衛所碩士論文陳明陽.王德予.黃瑞琮和陳連城 (2002) 台灣某一社區醫院對披衣菌感染的選擇性篩檢結果 台灣泌尿醫誌13, 108-113